Managing Protocol Amendments in Rare Disease Trials
Managing Protocol Amendments in Rare Disease Trials Effective Strategies for Handling Protocol Amendments in Rare Disease Studies Introduction: Why Protocol Amendments Are Common in Rare Disease Trials Rare disease clinical trials often undergo frequent protocol changes due to the evolving understanding of disease mechanisms, adaptive study designs, small patient populations, and safety considerations. These amendments—whether…
Read More “Managing Protocol Amendments in Rare Disease Trials” »